Adult Stem Cells Approved for ALS Clinical Trial
The U.S. company Neuralstem announced today that it has won approval from the FDA to begin clinical trials for the…
View ArticleBlog Articles
The U.S. company Neuralstem announced today that it has won approval from the FDA to begin clinical trials for the…
View ArticleAn international team of researchers has reported improvement in three patients with multiple sclerosis (MS), all of whom received autologous…
View ArticleIn his profession, job-related injuries are common. So when Buzz, a 3-year-old male Border Collie, was recently injured in his…
View ArticleIn the past, iPS (induced pluripotent stem) cells were obtained by reprogramming dermal fibroblasts obtained by skin biopsy, first in…
View ArticleThe renowned embryologist, Dr. James Thomson, of the University of Wisconsin at Madison, announced yesterday that he is merging 3…
View ArticleWhen Florida doctors could do no more to improve his failing heart, Jack flew to Thailand for help. In an…
View ArticleThe National Institute of Health has granted the Creighton School of Medicine $3.3 million dollars to study repairing damaged coronary…
View ArticleThe U.S. company Stem Cell Therapy International Inc. (SCII) today announced that it has agreed to litigation settlement terms with…
View ArticleOnce again, the biotech company Opexa Therapeutics announces strong preclinical data for its proprietary diabetes therapy, developed from autologous adult…
View Article